-
Rebecca Robbins
Posts
Biogen's Aduhelm Sales Total $2 Million in Second Quarter
The drug from Biogen, called Aduhelm, is expected to generate billions in sales. It could also strain Medicare’s budget within a few years.
Pfizer will turn to a plant in Africa to help supply the continent with vaccines next year.
The deal, which only involves the final stages of manufacturing, falls short of the technology transfer that public health activists have called for.